McKesson Corporation (MCK)
Health Care2 articles
Price chart
Why is MCK moving today?
+0.6%MCK is +0.6% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
McKesson Corporation (MCK) overview
McKesson is one of the largest U.S. pharmaceutical distributors.
MCK is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
McKesson Corporation trades on the NYSE under the ticker symbol MCK. The most recent market data puts the share price at about $1,004.84. That is up 0.62% on the session. At that price the company is worth roughly $117.15B.
Over the past 52 weeks, MCK has traded between $723.68 and $1,014.99. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 26.9. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns. MCK also pays a dividend. It yields around 0.37% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch MCK
MCK is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each MCK story as it breaks, and tags it bullish, bearish or neutral.
Size matters here as well. The S&P 500 is weighted by market value. MCK is large enough that its own share price nudges the whole index. So it is worth watching even for investors who only hold index funds.
What moves MCK
- Earnings. MCK reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from MCK.
- Sector news. Health Care stocks often move together, so a rival's news can move MCK too.
- Index weight. MCK is big enough to move the S&P 500 on its own.
Market Mood
Latest MCK news
McKesson (MCK) Director Sells $268,589 in Shares
Bradley Lerman, a director at McKesson (MCK), sold shares worth $268,589. This sale highlights insider trading activity within the company. Selling shares by company insiders can sometimes signal confidence levels in the business, affecting market perceptions. Investors often monitor insider transactions for insights about future company performance.
Read More: McKesson (MCK) Director Sells $268,589 in Shares
FDA Commissioner Marty Makary Resigns Amid Pressure
FDA Commissioner Marty Makary has resigned from his position. His departure comes amid reported pressures related to the Trump administration. The implications of this resignation on FDA operations remain unclear, but it may affect regulatory processes involved in drug approvals and public health initiatives. This situation could have a potential impact on pharmaceutical stocks and investor sentiment regarding the FDA's regulatory environment.
Read More: FDA Commissioner Marty Makary Resigns Amid PressureMore Health Care stocks
Frequently asked questions
Is McKesson Corporation in the S&P 500?
Yes. McKesson Corporation trades as MCK and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is MCK in?
MCK sits in the Health Care sector of the S&P 500.
Where can I find the latest MCK news?
Right here. This page collects recent MCK news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is McKesson Corporation's stock price?
MCK last traded at about $1,004.84. Prices move all through the session, so this is the latest quote rather than a live one.
What is McKesson Corporation's market cap?
MCK is worth roughly $117.15B. Market cap is the share price times the number of shares outstanding.
What is MCK's P/E ratio?
MCK trades at a trailing P/E ratio of about 26.9. The ratio compares the share price with earnings per share over the past year.